Apellis Pharmaceuticals, Inc. (APLS)

22.28 -0.52 (-2.28%) USD  |  NASDAQ  |  Feb 20, 16:00
22.28 0.00 (0.00%) Pre-Market: 20:00
More

Apellis Pharmaceuticals Current Deferred Liabilities (Quarterly)

Current Deferred Liabilities (Quarterly) Chart

View Current Deferred Liabilities (Quarterly) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Liabilities (Quarterly) Range, Past 5 Years

View Current Deferred Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Liabilities (Quarterly) Benchmarks

View Current Deferred Liabilities (Quarterly) Benchmarks
Start Trial
Amneal Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. --
Ionis Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade